Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CONMED Corporation - Common Stock
(NY:
CNMD
)
37.31
-1.38 (-3.57%)
Official Closing Price
Updated: 6:30 PM EST, Jan 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CONMED Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook
Today 0:37 EST
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2025, with sales up 7.9% year on year to $373.2 million. On the other hand, the company’s full-year revenue...
Via
StockStory
Topics
Economy
World Trade
CONMED Corp (NYSE:CNMD) Posts Q4 Earnings Beat but Offers Cautious 2026 Outlook
↗
January 28, 2026
Via
Chartmill
Topics
Earnings
CONMED (CNMD) Q4 2025 Earnings Call Transcript
↗
January 28, 2026
CONMED (CNMD) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Economy
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars
January 28, 2026
Medical tech company CONMED (NYSE:CNMD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.9% year on year to $373.2 million. On the other hand, the company’s...
Via
StockStory
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
CONMED Earnings: What To Look For From CNMD
January 26, 2026
Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
Surgical Equipment & Consumables - Diversified Stocks Q3 Results: Benchmarking CONMED (NYSE:CNMD)
January 13, 2026
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including CONMED (NYSE:CNMD) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Economy
3 Reasons to Sell CNMD and 1 Stock to Buy Instead
January 12, 2026
Over the past six months, CONMED’s stock price fell to $43.42. Shareholders have lost 13.3% of their capital, which is disappointing considering the S&P 500 has climbed by 11.1%. This may have...
Via
StockStory
Topics
Stocks
Supply Chain
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
January 09, 2026
What a brutal six months it’s been for CONMED. The stock has dropped 20.6% and now trades at $42.52, rattling many shareholders. This may have investors wondering how to approach the situation.
Via
StockStory
Topics
Supply Chain
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid
December 28, 2025
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via
StockStory
Why CONMED (CNMD) Stock Is Trading Up Today
December 17, 2025
Shares of medical tech company CONMED (NYSE:CNMD) jumped 3.3% in the afternoon session after positive sentiment in the medical device sector was buoyed by the highly successful initial public offering...
Via
StockStory
Topics
Initial Public Offering
3 Russell 2000 Stocks That Concern Us
December 15, 2025
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...
Via
StockStory
Why CONMED (CNMD) Shares Are Plunging Today
December 05, 2025
Shares of medical tech company CONMED (NYSE:CNMD) fell 6.2% in the morning session after the company announced its plan to exit its gastroenterology product lines as part of a broader portfolio...
Via
StockStory
Topics
Artificial Intelligence
Economy
3 Value Stocks We’re Skeptical Of
December 03, 2025
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...
Via
StockStory
3 of Wall Street’s Favorite Stocks We Think Twice About
December 01, 2025
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...
Via
StockStory
3 Healthcare Stocks We Steer Clear Of
November 24, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but...
Via
StockStory
Topics
Stocks
CONMED, Select Medical, BrightSpring Health Services, Privia Health, and RadNet Shares Are Soaring, What You Need To Know
November 21, 2025
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...
Via
StockStory
Topics
Economy
1 Cash-Producing Stock Worth Your Attention and 2 We Turn Down
November 12, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...
Via
StockStory
Topics
Economy
5 Insightful Analyst Questions From CONMED’s Q3 Earnings Call
November 12, 2025
CONMED’s third quarter results were marked by steady revenue growth in both orthopedics and general surgery, supported by continued surgeon adoption of core products like BioBrace and the AirSeal...
Via
StockStory
Topics
Earnings
Economy
World Trade
3 Small-Cap Stocks We’re Skeptical Of
November 09, 2025
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...
Via
StockStory
Topics
Artificial Intelligence
CNMD Q3 Deep Dive: Margin Pressures and Portfolio Focus Shape Guidance
November 06, 2025
Medical tech company CONMED (NYSE:CNMD) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 6.7% year on year to $337.9 million. The company expects the full year’s revenue...
Via
StockStory
Topics
Economy
World Trade
CONMED (NYSE:CNMD) Posts Better-Than-Expected Sales In Q3, Stock Soars
November 05, 2025
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q3 CY2025, with sales up 6.7% year on year to $337.9 million. The company expects the full year’s revenue to be around...
Via
StockStory
CONMED (CNMD) To Report Earnings Tomorrow: Here Is What To Expect
November 03, 2025
Medical tech company CONMED (NYSE:CNMD) will be reporting results this Wednesday after market close. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Q2 Earnings Roundup: CONMED (NYSE:CNMD) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment
October 19, 2025
Let’s dig into the relative performance of CONMED (NYSE:CNMD) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season.
Via
StockStory
Topics
Artificial Intelligence
Economy
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know
October 10, 2025
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Via
StockStory
Topics
Economy
Government
World Trade
3 Stocks Under $50 with Open Questions
October 02, 2025
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...
Via
StockStory
Topics
Retirement
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...
Via
StockStory
Topics
Government
World Trade
1 Healthcare Stock with Exciting Potential and 2 We Question
September 30, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...
Via
StockStory
Topics
Stocks
Solventum, CONMED, and STERIS Shares Are Falling, What You Need To Know
September 25, 2025
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...
Via
StockStory
Topics
Stocks
World Trade
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
